FacebookTwitterGoogle+RedditEmail

How Patients Who “Kill the Messenger” Are Pharma’s Best Salespeople

by

Photo by Charles Williams | CC BY 2.0

“Prince was not addicted to pain medication. Prince had a medical condition — chronic pain –which is criminally under-treated…. Physical dependence is not addiction.” So reads one of many articles that defend opioids and blame their restrictions for the nation’s opioid crisis. Right.

When journalists present evidence of a prescription drug being dangerous, ineffective, unethically marketed and even unnecessary we are often met with: “How dare you suggest I am not sick?” “You’re not taking my drugs!” They sound like gun advocates whose response to better background check laws for guns is “you’re not taking my gun.”

Thanks to aggressive Pharma marketing, seven out of ten Americans now take a prescription drug and many of the drugs are far from safe.

* 100 people a day die in the US from opioids.

* Statins are linked to memory loss

* GERD meds are linked to early death risks

* SSRI antidepressants are linked to suicide

Pharma has succeeded, through millions of dollars of advertising, in doing two cagey things: it has convinced people who might actually be fine that they have “depression,” GERD and other conditions and it has downplayed the risks of drugs to treat those conditions. Pharma’s maneuver affects more than the drug takers–it raises everyone’s health care costs and taxes through selling expensive, brand-name drugs. Usually safer and less expensive drugs are available–if people even need drugs at all. Often they don’t.

Consider SSRI antidepressants. Before the advent of Prozac, depression was not a permanent condition for which people took life-long drugs. It was a self-limited condition that would go away on its own, respond to psychotherapy and/or respond to short-term drugs. Now, roughly a quarter of the population takes antidepressants, sometimes, shockingly, for decades. Often their “depression” is really problems with money, health, jobs and family. When SSRI antidepressants stop working because they have been used for too long or don’t work to begin with because the person never had “depression,” Pharma tells patients they need to add more expensive drugs, furthering profiting, and patients comply. No wonder Pharma is the third most lucrative industry in the US.

Whereas it takes thirty seconds for a doctor to prescribe such psychoactive drugs, it can take years for a person to titrate off them, faced with a host of very unpleasant withdrawal symptoms. SSRI antidepressants also cause weight gain, sexual dysfunction and sometimes bizarre and violent behavior.

Psychoactive drugs are especially dangerous in children. Today, millions of children are given drugs for ADHD, oppositional defiant disorder, obsessive-compulsive disorders, mixed manias, pervasive development disorders and more, pushed by their parents, doctors and teachers. Their chances of going on to lead drug-free lives are very slim—-they have never been “straight”—- and Pharma has actual marketing plans to keep children on such drugs as life-long customers when they leave home.

GERD medicines (proton pump inhibitors or PPIs) which millions have been convinced to use are linked to dangerous “C dif” infections, osteoporosis, bone fractures and an increased risk of death. Like statins, which were among the most popular drugs in the world, GERD meds are not as safe as originally presented. Worse–most users do not have GERD but simple heartburn.

And opioids? In addition to addiction and death, they are linked to hormonal changes, constipation, a decrease in immune responses, fracture risks, liver and kidney risks, cardiopulmonary, pulmonary and congestive heart problems, sleep apnea and mental problems. In some cases, opioids actually cause rather than relieve pain a phenomenon called opioid-induced hyperalgesia (OIH).

To sell its high priced, often dangerous drugs Pharma has long created phony “patient groups” who lobby Congress and state Medicaid programs to pry loose our tax dollars. But “kill the messenger” patients are just as useful to Pharma’s marketing plans.

After a recent scientific study found “Adult ADHD” to be exaggerated if it exists at all this is what one patient wrote:

“Executive dysfunction [adult ADHD[ is real and f***you for suggesting otherwise…You should feel really bad for publishing this f*** abomination. Way to invalidate millions of people and their lived experiences.”

Rather than anger at doctors who hooked them on opioids or ADHD stimulant drugs like Adderall, Concerta and Vyvanse, these patients want to kill the messenger––journalists who report the scam. And Pharma likes that just fine.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

December 21, 2017
Richard Moser
Whiteness Won’t Be Wished Away
David Mattson
Becoming Grizzly Bear Food
Kenneth Surin
Do I Live in a Banana Republic?
Michael Doliner
Simone Weil, Marx and Revolution
Jason Hickel
In Defense of Degrowth
Chris Gilbert
Chavist vs. Chavist: Class Struggle on the Rise Following Venezuela’s Local Elections
Thomas Hon Wing Polin
The Rogue Cries Rogue: Trump’s New National Security Policy
Thomas Knapp
Trump’s “National Security Strategy” is the Opposite of National Security
Kumar Sundaram
Nuking Narmada: Uprooting Lives and Compounding Climate Crisis Impacts
Roy Morrison
The Bitcoin Bubble
December 20, 2017
Jonathan Cook
Team Trump Adds Insult to Injury for the Palestinians
Vicente Navarro
What is Happening in Catalonia and Spain?
Nick Pemberton
The Internet is Already Broken
Dave Lindorff
The Big Lie About the Tax Bill: Why Bosses Will Never Raise Wages
ADRIAN KUZMINSKI
The Counter-Revolution
Ramzy Baroud
Whitewashing: The Media’s Two Narratives on Terrorism
Patricio Zamorano
The Silent Cry of Honduras
Dean Baker
Tax Cuts, Growth and Debt
Patrick Bond
In South Africa, Ramaphosa Rises as Lonmin Expires Workers, Women and Communities Prepare to Fight, Not Mourn
Tom Crofton
Sea Change or Rogue Wave?
Ted Rall
Sexism Sucks, But Blame Capitalism More
Jesse Jackson
The South Can Lead the Nation to a New Politics
December 19, 2017
Donna M. Goldstein
Gen. Flynn Goes Nuclear: Reactor Projects, Corruption and the Russia Inquiry
John Davis
Ring of Fire
Louis Proyect
Political Paradoxes: “The Post” and the Pentagon Papers
Todd Morten
Why Killer Cops Walk
Binoy Kampmark
Preconditions to Conditions: Rex Tillerson on North Korea
Jonathan Fenton-Harvey
How Another ISIS Could Emerge
Rivera Sun
Net Neutrality: Gandhi’s Salt For US
David Swanson
The Even More Dangerous Case of Donald Trump
Robert Abele
Reactionary Movements are Not Revolutionary
Aidan O'Brien
Why Can’t France Leave Africa Alone? 
Colin Todhunter
Import and Die: Self-sufficiency and Food Security in India
Edward Curtin
An Advent Calendar to Beat the Devil
CounterPunch News Service
An Open Letter to the US Embassy in Tegucigalpa on the Crisis in Honduras
December 18, 2017
Robert Hunziker
Pesticide Suicide
Shamus Cooke
Will the Supreme Court Break or Remake the Labor Movement?
David Rosen
Is It Finally Time to Decriminalize Prostitution?
Martha Rosenberg
How Patients Who “Kill the Messenger” Are Pharma’s Best Salespeople
Rob Seimetz
Adapt or Die: Millennials, Technology, and Net Neutrality
Uri Avnery
Children of Stone
Julian Vigo
UK Proposes New Surveillance Body
Patrick Cockburn
Cracks in the House of Saud: the Pratfalls of the Crown Prince
Howard Lisnoff
Dustin Hoffman in the Gene McCarthy for President Campaign
Chris Gilbert
Mutant October: Learning from the Rough Beast of Revolution
FacebookTwitterGoogle+RedditEmail